Q2 Korean Biotech Roundup: Partners Return Multiple Assets

U-Turns For OliX, Artiva, Voronoi

 
• By Jung Won Shin
deal break
Korean Biotech Sector Lacks Major Positive News In Q2 • Source: Shutterstock

More from South Korea

More from Focus On Asia